Abnormally high NF-κB activity in many cancers, due to genetic mutations, chronic inflammation and exposure to carcinogens, contributes to cancer development and progression through mechanisms such as promoting cell proliferation, inhibiting apoptosis, facilitating angiogenesis and triggering epithelial-to-mesenchymal transition (EMT) [58]. The gene discussed is NFKB1; the disease is cancer.